{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:05:30Z","timestamp":1793315130519,"version":"4.5.0"},"reference-count":287,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,7,16]],"date-time":"2017-07-16T00:00:00Z","timestamp":1500163200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s12016-017-8625-4","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T22:37:43Z","timestamp":1500158263000},"page":"306-336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":185,"title":["Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8223-6791","authenticated-orcid":false,"given":"Caterina","family":"Ferreli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Parodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Rongioletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Atzori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,16]]},"reference":[{"key":"8625_CR1","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","volume":"360","author":"A Gabrielli","year":"2009","unstructured":"Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360:1989\u20132003","journal-title":"N Engl J Med"},{"key":"8625_CR2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0889-857X(03)00022-X","volume":"29","author":"MD Mayes","year":"2003","unstructured":"Mayes MD (2003) Scleroderma epidemiology. Rheum Dis Clin North Am 29:239\u2013254","journal-title":"Rheum Dis Clin North Am"},{"key":"8625_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/annrheumdis-2014-206386","volume":"75","author":"M Elhai","year":"2016","unstructured":"Elhai M, Avouac J, Walker UA, Matucci-Cerinic M, Riemekasten G, Airo P et al (2016) A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. Ann Rheum Dis 75:163\u2013169","journal-title":"Ann Rheum Dis"},{"key":"8625_CR4","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/art.34482","volume":"64","author":"V Steen","year":"2012","unstructured":"Steen V, Domsic RT, Lucas M, Fertig N, Medsger TA Jr (2012) A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosis. Arthritis Rheum 64:2986\u20132994","journal-title":"Arthritis Rheum"},{"key":"8625_CR5","first-page":"1004","volume":"33","author":"K Scalapino","year":"2006","unstructured":"Scalapino K, Arkachaisri T, Lucas M, Fertig N, Helfrich DJ, Londino AV Jr, Steen VD, Medsger TA Jr (2006) Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease. J Rheumatol 33:1004\u20131013","journal-title":"J Rheumatol"},{"key":"8625_CR6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik D, Brown M, Postlethwaite BC, Postlethwaite AE (2015) Pathogenesis of systemic sclerosis. Front Immunol 6:272","journal-title":"Front Immunol"},{"key":"8625_CR7","first-page":"1481","volume":"32","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Kung TN, Siannis F, Pellett F, Farewell VT, Lee P (2005) HLA markers for susceptibility and expression in scleroderma. J Rheumatol 32:1481\u20131487","journal-title":"J Rheumatol"},{"key":"8625_CR8","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","volume":"42","author":"TR Radstake","year":"2010","unstructured":"Radstake TR, Gorlova O, Rueda B et al (2010) Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet 42:426\u2013429","journal-title":"Nat Genet"},{"key":"8625_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00281-015-0551-z","volume":"38","author":"O Distler","year":"2016","unstructured":"Distler O, Cozzio A (2016) Systemic sclerosis and localized scleroderma\u2014current concepts and novel targets for therapy. Semin Immunopathol 38:87\u201395","journal-title":"Semin Immunopathol"},{"key":"8625_CR10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/01.bor.0000245727.40630.c3","volume":"18","author":"RM Laxer","year":"2006","unstructured":"Laxer RM, Zulian F (2006) Localized scleroderma. Curr Opin Rheumatol 18:606\u2013613","journal-title":"Curr Opin Rheumatol"},{"key":"8625_CR11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jaad.2014.04.009","volume":"71","author":"D Grabell","year":"2014","unstructured":"Grabell D, Hsieh C, Andrew R, Martires K, Kim A, Vasquez R et al (2014) The role of skin trauma in the distribution of morphea lesions: a cross-sectional survey of the morphea in adults and children cohort IV. J Am Acad 71:493\u2013498","journal-title":"J Am Acad"},{"key":"8625_CR12","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic M, Kahaleh B, Wigley FM (2013) Evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 65:1953\u20131962","journal-title":"Arthritis Rheum"},{"key":"8625_CR13","first-page":"105","volume":"4","author":"D Pattanaik","year":"2011","unstructured":"Pattanaik D, Brown M, Postlethwaite AE (2011) Vascular involvement in systemic sclerosis (scleroderma). J Inflamm Res 4:105\u2013125","journal-title":"J Inflamm Res"},{"key":"8625_CR14","first-page":"198","volume":"66","author":"J Varga","year":"2008","unstructured":"Varga J (2008) Systemic sclerosis an update. Bull NYU Hosp Jt Dis 66:198\u2013202","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"8625_CR15","first-page":"389","volume":"2","author":"MD Kraaij","year":"2008","unstructured":"Kraaij MD, van Laar JM (2008) The role of B cells in systemic sclerosis. Biologics 2:389\u2013395","journal-title":"Biologics"},{"key":"8625_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5021\/ad.2015.27.1.1","volume":"27","author":"A Yoshizaki","year":"2015","unstructured":"Yoshizaki A, Sato S (2015) Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol 27:1\u20139","journal-title":"Ann Dermatol"},{"key":"8625_CR17","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.rdc.2015.04.002","volume":"41","author":"EP Stern","year":"2015","unstructured":"Stern EP, Denton CP (2015) The pathogenesis of systemic sclerosis. Rheum Dis Clin N Am 41:367\u2013382","journal-title":"Rheum Dis Clin N Am"},{"key":"8625_CR18","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F Hoogen van den","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A et al (2013) Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 72:1747\u20131755","journal-title":"Ann Rheum Dis"},{"key":"8625_CR19","doi-asserted-by":"crossref","first-page":"e0163894","DOI":"10.1371\/journal.pone.0163894","volume":"11","author":"VK Jaeger","year":"2016","unstructured":"Jaeger VK, Wirz EG, Allanore Y, Rossbach P, Riemekasten G, Hachulla E, Distler O, Air\u00f2 P, Carreira PE, Balbir Gurman A, Tikly M, Vettori S, Damjanov N, M\u00fcller-Ladner U, Distler JH, Li M, Walker UA, EUSTAR Co-authors (2016) Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS One 11:e0163894","journal-title":"PLoS One"},{"key":"8625_CR20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2016.01.007","volume":"15","author":"AC Desbois","year":"2016","unstructured":"Desbois AC, Cacoub P (2016) Systemic sclerosis: an update in 2016. Autoimmun Rev 15:417\u2013426","journal-title":"Autoimmun Rev"},{"key":"8625_CR21","doi-asserted-by":"crossref","first-page":"1355e60","DOI":"10.1136\/annrheumdis-2011-200742","volume":"71","author":"FM Meier","year":"2012","unstructured":"Meier FM, Frommer KW, Dinser R et al (2012) Update on the profile of the EUSTAR cohort: an analysis of the EULAR scleroderma trials and research group database. Ann Rheum Dis 71:1355e60","journal-title":"Ann Rheum Dis"},{"key":"8625_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.berh.2016.04.001","volume":"30","author":"M Hughes","year":"2016","unstructured":"Hughes M, Herrick AL (2016) Raynaud\u2019s phenomenon. Best Pract Res Clin Rheumatol 30:112\u2013132","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8625_CR23","first-page":"476e81","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, Fransen J, Walker UA et al (2011) Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi consensus study from EULAR scleroderma trials and research group. Ann Rheum Dis 70:476e81","journal-title":"Ann Rheum Dis"},{"key":"8625_CR24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1136\/annrheumdis-2013-203716","volume":"73","author":"T Minier","year":"2014","unstructured":"Minier T, Guiducci S, Bellando-Randone S, Bruni C, Lepri G, Czirjak L et al (2014) Preliminary analysis of the very early diagnosis of systemic sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis. Ann Rheum Dis 73:2087\u20132093","journal-title":"Ann Rheum Dis"},{"key":"8625_CR25","first-page":"1892","volume":"20","author":"PJ Clements","year":"1993","unstructured":"Clements PJ, Lachenbruch PA, Seibold JR, Zee B, Steen VD, Brennan P et al (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20:1892\u20131896","journal-title":"J Rheumatol"},{"issue":"Suppl. 91","key":"8625_CR26","first-page":"S3","volume":"33","author":"S Barsotti","year":"2015","unstructured":"Barsotti S, Stagnaro C, Della Rossa A (2015) Systemic sclerosis: a critical digest of the recent literature. Clin Exp Rheumatol 33(Suppl. 91):S3\u201314","journal-title":"Clin Exp Rheumatol"},{"key":"8625_CR27","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1136\/ard.2006.066530","volume":"66","author":"L Czirj\u00e1k","year":"2007","unstructured":"Czirj\u00e1k L, Nagy Z, Aringer M et al (2007) The EUSTAR model for teaching and implementing the modified Rodnan skin score in systemic sclerosis. Ann Rheum Dis 66:966\u2013969","journal-title":"Ann Rheum Dis"},{"key":"8625_CR28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s13075-015-0853-5","volume":"17","author":"R Hesselstrand","year":"2015","unstructured":"Hesselstrand R, Carlestam J, Wildt M, Sandqvist G, Andr\u00e9asson K (2015) High frequency ultrasound of skin involvement in systemic sclerosis\u2014a follow-up study. Arthritis Res Ther 17:329","journal-title":"Arthritis Res Ther"},{"issue":"Suppl. 100","key":"8625_CR29","first-page":"S137","volume":"34","author":"T Santiago","year":"2016","unstructured":"Santiago T, Alcacer-Pitarch B, Salvador MJ, Del Galdo F, Redmond AC, da Silva JAP (2016) A preliminary study using virtual touch imaging and quantification for the assessment of skin stiffness in systemic sclerosis. Clin Exp Rheumatol 34(Suppl. 100):S137\u2013S141","journal-title":"Clin Exp Rheumatol"},{"key":"8625_CR30","doi-asserted-by":"crossref","first-page":"114","DOI":"10.11604\/pamj.2013.16.114.3065","volume":"16","author":"B Salem","year":"2013","unstructured":"Salem B, Rim BH, Sihem BK, Maher B (2013) Oral manifestations of systemic sclerosis. Pan Afr Med J 16:114","journal-title":"Pan Afr Med J"},{"key":"8625_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5455\/medarh.2015.69.153-156","volume":"69","author":"IH Bajraktari","year":"2015","unstructured":"Bajraktari IH, Kryeziu A, Sherifi F, Bajraktari H, Lahu A, Bajraktari G (2015) Oral manifestations of systemic sclerosis and correlation with anti-topoisomerase I antibodies (SCL-70). Med Arch 69:153\u2013156","journal-title":"Med Arch"},{"key":"8625_CR32","first-page":"S44","volume":"27","author":"S Maddali Bongi","year":"2009","unstructured":"Maddali Bongi S, Del Rosso A, Galluccio F, Tai G, Sigismondi F, Passalacqua M, Landi G, Baccini M, Conforti ML, Miniati I et al (2009) Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol 27:S44\u2013S50","journal-title":"Clin Exp Rheumatol"},{"key":"8625_CR33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.17126\/joralres.2015.065","volume":"4","author":"J Silvestre-Rangil","year":"2015","unstructured":"Silvestre-Rangil J, Martinez-Herrera M, Silvestre FJ (2015) Dental management of patients with microstomia. A review of the literature and update on the treatment. J Oral Res 4:340\u2013350","journal-title":"J Oral Res"},{"key":"8625_CR34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3390\/ijms17071189","volume":"17","author":"V Crincoli","year":"2016","unstructured":"Crincoli V, Fatone L, Fanelli M, Rotolo RP, Chial\u00e0 A, Favia G, Lapadula G (2016) Orofacial manifestations and temporomandibular disorders of systemic scleroderma: an observational study. Int J Mol Sci 17:1189","journal-title":"Int J Mol Sci"},{"key":"8625_CR35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4103\/0972-124X.99275","volume":"16","author":"R Jagadish","year":"2012","unstructured":"Jagadish R, Mehta DS, Jagadish P (2012) Oral and periodontal manifestations associated with systemic sclerosis: a case series and review. J Indian Soc Periodontol 16:271\u2013274","journal-title":"J Indian Soc Periodontol"},{"key":"8625_CR36","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.ijom.2011.02.026","volume":"40","author":"A Aliko","year":"2011","unstructured":"Aliko A, Ciancaglini R, Alushi A, Tafaj A, Ruci D (2011) Temporomandibular joint involvement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis. Int J Oral Maxillofac Surg 40:704\u2013709","journal-title":"Int J Oral Maxillofac Surg"},{"key":"8625_CR37","first-page":"S3","volume":"33","author":"CP Denton","year":"2015","unstructured":"Denton CP (2015) Systemic sclerosis: from pathogenesis to targeted therapy. Clin Exp Rheumatol 33:S3\u2013S7","journal-title":"Clin Exp Rheumatol"},{"key":"8625_CR38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mvr.2016.12.003","volume":"111","author":"C Pizzorni","year":"2016","unstructured":"Pizzorni C, Giampetruzzi AR, Mondino C, Facchiano A, Abeni D, Paolino S, Ruaro B, Smith V, Sulli A, Cutolo M (2016) Nailfold capillaroscopic parameters and skin telangiectasia patterns in patients with systemic sclerosis. Microvasc Res 111:20\u201324","journal-title":"Microvasc Res"},{"key":"8625_CR39","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/annrheumdis-2011-200780","volume":"71","author":"V Smith","year":"2012","unstructured":"Smith V, Decuman S, Sulli A, Bonroy C, Piettte Y, Deschepper E et al (2012) Do worsening scleroderma capillaroscopic pattern predict future severe organ involvement? A pilot study. Ann Rheum Dis 71:1636\u20131639","journal-title":"Ann Rheum Dis"},{"key":"8625_CR40","doi-asserted-by":"crossref","first-page":"150","DOI":"10.11604\/pamj.2014.18.150.4637","volume":"18","author":"I Elmansour","year":"2014","unstructured":"Elmansour I, Chiheb S, Benchikhi H (2014) Nail changes in connective tissue diseases: a study of 39 cases. Pan Afr Med J 18:150","journal-title":"Pan Afr Med J"},{"key":"8625_CR41","doi-asserted-by":"publisher","unstructured":"Marie I, Gremain V, Nassermadji K, Richard L, Joly P, Menard JF, Levesque H (2016) Nail involvement in systemic sclerosis. J Am Acad Dermatol. doi: 10.1016\/j.jaad.2016.11.024","DOI":"10.1016\/j.jaad.2016.11.024"},{"key":"8625_CR42","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0019-5154.30291","volume":"51","author":"PA Nabil","year":"2006","unstructured":"Nabil PA, Rao RA, Shrutakirti Shenoi D, Balachandran C (2006) Nail unit in collagen vascular diseases: a clinical, histopathological and direct immunofluorescence study. Indian J Dermatol 51:265\u2013268","journal-title":"Indian J Dermatol"},{"key":"8625_CR43","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1468-3083.2006.02012.x","volume":"21","author":"SE Tunc","year":"2007","unstructured":"Tunc SE, Ertam I, Pirildar T, Turk T, Ozturk M, Doganavsargil E (2007) Nail changes in connective tissue diseases: do nail changes provide clues for the diagnosis? J Eur Acad Dermatol Venereol 21:497\u2013503","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR44","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jaad.2010.12.035","volume":"66","author":"N Sultan-Bichat","year":"2012","unstructured":"Sultan-Bichat N, Menard J, Perceau G, Staerman F, Bernard P, Reguia Z (2012) Treatment of calcinosis cutis by extracorporeal shock-wave lithotripsy. J Am Acad Dermatol 66:424\u2013429","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR45","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1093\/rheumatology\/kes214","volume":"51","author":"EM Johnstone","year":"2012","unstructured":"Johnstone EM, Hutchinson CE, Vail A, Chevance A, Herrick AL (2012) Acro-osteolysis in systemic sclerosis is associated with digital ischemia and severe calcinosis. Rheumatology 51:2234\u20132238","journal-title":"Rheumatology"},{"key":"8625_CR46","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/ard.2010.134304","volume":"70","author":"J Avouac","year":"2011","unstructured":"Avouac J, Mogavero G, Guerini H et al (2011) Predictive factors of hand radiographic lesions in systemic sclerosis: a prospective study. Ann Rheum Dis 70:630\u2013633","journal-title":"Ann Rheum Dis"},{"key":"8625_CR47","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.semarthrit.2010.06.008","volume":"40","author":"S Koutaissoff","year":"2011","unstructured":"Koutaissoff S, Vanthuyne M, Smith V et al (2011) Hand radiological damage in systemic sclerosis: comparison with a control group and clinical and functional correlations. Semin Arthritis Rheum 40:455\u2013460","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR48","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3899\/jrheum.130171","volume":"40","author":"AR Giampetruzzi","year":"2013","unstructured":"Giampetruzzi AR, Mondino C, Facchiano A, Bono R, Puddu P, Didona B, Abeni D, Cutolo M (2013) Association of dermoscopic profiles of telangiectases with nailfold videocapillaroscopic patterns in patients with systemic sclerosis. J Rheumatol 40:1630\u20131632","journal-title":"J Rheumatol"},{"key":"8625_CR49","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1002\/acr.22766","volume":"68","author":"C Hurabielle","year":"2016","unstructured":"Hurabielle C, Avouac J, Lepri G, de Risi T, Kahan A, Allanore Y (2016) Skin telangiectasia and the identification of a subset of systemic sclerosis patients with severe vascular disease. Arthritis Care Res 68:1021\u20131027","journal-title":"Arthritis Care Res"},{"key":"8625_CR50","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/ard.2010.130658","volume":"70","author":"M Matucci-Cerinic","year":"2011","unstructured":"Matucci-Cerinic M, Denton CP, Furst DE, Mayes MD, Hsu VM, Carpentier P et al (2011) Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial. Ann Rheum Dis 70:32\u201338","journal-title":"Ann Rheum Dis"},{"key":"8625_CR51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O et al (2007) Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database. Ann Rheum Dis 66:754\u2013763","journal-title":"Ann Rheum Dis"},{"key":"8625_CR52","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.autrev.2015.07.012","volume":"14","author":"C Almeida","year":"2015","unstructured":"Almeida C, Almeida I, Vasconcelos C (2015) Quality of life in systemic sclerosis. Auto Immun Rev 14:1087\u20131096","journal-title":"Auto Immun Rev"},{"key":"8625_CR53","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1136\/annrheumdis-2011-200631","volume":"71","author":"CP Denton","year":"2012","unstructured":"Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M et al (2012) De- mographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: data from the DUO registry. Ann Rheum Dis 71:718\u2013721","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 91","key":"8625_CR54","first-page":"S47","volume":"33","author":"M Brand","year":"2015","unstructured":"Brand M, Hollaender R, Rosenberg D, Scott M, Hunsche E, Tyndall A, Denaro V, EUSTAR Co-investigators et al (2015) An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. Clin Exp Rheumatol 33(4 Suppl 91):S47\u2013S54","journal-title":"Clin Exp Rheumatol"},{"key":"8625_CR55","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","volume":"75","author":"C Mihai","year":"2016","unstructured":"Mihai C, Landewe R, van der Heijde D, Walker UA, Constantin PI, Gherghe AM et al (2016) Digital ulcers predict a worse disease course in patients with systemic sclerosis. Ann Rheum Dis Ann Rheum Dis 75:681\u2013686","journal-title":"Ann Rheum Dis Ann Rheum Dis"},{"key":"8625_CR56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/rheumatology\/kel310","volume":"45","author":"M Cutolo","year":"2006","unstructured":"Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C (2006) Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement? Rheumatology 45:43\u201346","journal-title":"Rheumatology"},{"key":"8625_CR57","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.24394","volume":"61","author":"M Sebastiani","year":"2009","unstructured":"Sebastiani M, Manfredi A, Colaci M, D\u2019amico R, Malagoli V, Giuggioli D et al (2009) Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum 61:688\u2013694","journal-title":"Arthritis Rheum"},{"key":"8625_CR58","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mvr.2015.06.009","volume":"101","author":"B Ruaro","year":"2015","unstructured":"Ruaro B, Sulli A, Smith V, Paolino S, Pizzorni C, Cutolo M (2015) Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients. Microvasc Res 101:82\u201385","journal-title":"Microvasc Res"},{"key":"8625_CR59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2016.11.003","volume":"110","author":"B Barbano","year":"2016","unstructured":"Barbano B, Marra AM, Quarta S, Gigante A, Barilaro G, Gasperini ML, Rosato E (2016) In systemic sclerosis skin perfusion of hands is reduced and may predict the occurrence of new digital ulcers. Microvasc Res 110:1\u20134","journal-title":"Microvasc Res"},{"key":"8625_CR60","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/rheumatology\/kel330","volume":"46","author":"ME Anderson","year":"2007","unstructured":"Anderson ME, Moore TL, Lunt M, Herrick AL (2007) The \u2018distal-dorsal difference\u2019: a thermographic parameter by which to differentiate between primary and secondary Raynaud\u2019s phenomenon. Rheumatology 46:533\u2013538","journal-title":"Rheumatology"},{"key":"8625_CR61","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2169\/internalmedicine.52.1291","volume":"52","author":"S Onishi","year":"2013","unstructured":"Onishi S, Homma Y, Hasegawa H, Yasukawa M (2013) Multiple tumoral calcinosis in systemic sclerosis. Intern Med 52:2689","journal-title":"Intern Med"},{"key":"8625_CR62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/BOR.0000000000000220","volume":"27","author":"A Valenzuela","year":"2015","unstructured":"Valenzuela A, Chung L (2015) Calcinosis: pathophysiology and management. Curr Opin Rheumatol 27:542\u2013548","journal-title":"Curr Opin Rheumatol"},{"key":"8625_CR63","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.rbr.2013.01.001","volume":"53","author":"AF Zimmermann","year":"2013","unstructured":"Zimmermann AF, Pizzichini MM (2013) Update on etiopathogenesis of systemic sclerosis. Rev Bras Reumatol 53:516\u2013524","journal-title":"Rev Bras Reumatol"},{"key":"8625_CR64","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2230.2011.04100.x","volume":"36","author":"V Vachiramon","year":"2011","unstructured":"Vachiramon V (2011) Approach to reticulate hyperpigmentation. Clin Exp Dermatol 36:459\u2013466","journal-title":"Clin Exp Dermatol"},{"key":"8625_CR65","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2230.2004.01683.x","volume":"30","author":"HL Ee","year":"2005","unstructured":"Ee HL, Tan SH (2005) Reticulate hyperpigmented scleroderma: a new pigmentary manifestation. Clin Exp Dermatol 30:131\u2013133","journal-title":"Clin Exp Dermatol"},{"key":"8625_CR66","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/rheumatology\/kew003","volume":"55","author":"J Ziemek","year":"2016","unstructured":"Ziemek J, Man A, Hinchcliff M, Varga J, Simms RW, Lafyatis R (2016) The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis. Rheumatology 55:911\u2013917","journal-title":"Rheumatology"},{"key":"8625_CR67","doi-asserted-by":"publisher","unstructured":"Krieg T, Takehara K (2009) Skin disease: a cardinal feature of systemic sclerosis. Rheumatology (Oxford). doi: 10.1093\/rheumatology\/kep108","DOI":"10.1093\/rheumatology\/kep108"},{"key":"8625_CR68","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000246821","volume":"189","author":"F Rongioletti","year":"1994","unstructured":"Rongioletti F, Gambini C, Micalizzi C, Pastorino A, Rebora A (1994) Mucin deposits in morphea and systemic scleroderma. Dermatology 189:157\u2013158","journal-title":"Dermatology"},{"key":"8625_CR69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","volume":"64","author":"N Fett","year":"2011","unstructured":"Fett N, Werth VP (2011) Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis. J Am Acad Dermatol 64:217\u2013228","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR70","first-page":"1","volume":"7","author":"A Kreuter","year":"2009","unstructured":"Kreuter A, Krieg T, Worm M et al (2009) AWMF guideline no. 013\/066. Diagnosis and therapy of circumscribed scleroderma. J Dtsch Dermatol Ges 7:1\u201314","journal-title":"J Dtsch Dermatol Ges"},{"key":"8625_CR71","first-page":"80","volume":"5","author":"KT Ho","year":"2003","unstructured":"Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5:80\u201393","journal-title":"Arthritis Res Ther"},{"key":"8625_CR72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4236\/ojra.2015.53013","volume":"5","author":"A Kelly","year":"2015","unstructured":"Kelly A, Derk CT (2015) Anti-RNA polymerase III antibodies in systemic sclerosis. Open J Rheumatol Autoimmune Dis 5:81\u201386","journal-title":"Open J Rheumatol Autoimmune Dis"},{"key":"8625_CR73","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Fertig N, Pino S, Medsger TA Jr (2008) Serum autoantibodies and their clinical associations in patients with childhood- and adult-onset linear scleroderma. A single-center study. J Rheumatol 35:2439\u20132444","journal-title":"J Rheumatol"},{"key":"8625_CR74","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2012.01.003","volume":"42","author":"KM Walker","year":"2012","unstructured":"Walker KM, Pope J, participating members of the Scleroderma Clinical Trials Consortium (SCTC), Canadian Scleroderma Research Group (CSRG) (2012) Treatment of systemic sclerosis complications: what to use when first-line treatment fails\u2014a consensus of systemic sclerosis experts. Semin Arthritis Rheum 42:42\u201355","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR75","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","volume":"44","author":"JE Pope","year":"2001","unstructured":"Pope JE, Bellamy N, Seibold JR et al (2001) A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma. Arthritis Rheum 44:1351\u20131358","journal-title":"Arthritis Rheum"},{"key":"8625_CR76","doi-asserted-by":"publisher","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Lancet. doi: 10.1016\/S0140-6736(17)30933-9","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"8625_CR77","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","volume":"354","author":"DP Tashkin","year":"2006","unstructured":"Tashkin DP, Elashoff R, Clements PJ, the Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655\u20132666","journal-title":"N Engl J Med"},{"key":"8625_CR78","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/phpp.12185","volume":"31","author":"KL Connolly","year":"2015","unstructured":"Connolly KL, Griffith JL, McEvoy M, Lim HW (2015) Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients. Photodermatol Photoimmunol Photomed 31:289\u2013295","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8625_CR79","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Landew\u00e9 R, Avouac J, Chwiesko S, Miniati I et al (2009) EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR scleroderma trials and research group (EUSTAR). Ann Rheum Dis 68:620\u2013628","journal-title":"Ann Rheum Dis"},{"key":"8625_CR80","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.131210","volume":"41","author":"L Mouthon","year":"2014","unstructured":"Mouthon L, Bussone G, Berezn\u00e9 A, No\u00ebl LH, Guillevin L (2014) Scleroderma renal crisis. J Rheumatol 41:1040\u20131048","journal-title":"J Rheumatol"},{"key":"8625_CR81","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.clim.2011.09.014","volume":"142","author":"G Papp","year":"2012","unstructured":"Papp G, Horvath IF, Barath S et al (2012) Immunomodulatory effects of extracorporeal photochemotherapy in systemic sclerosis. Clin Immunol 142:150\u2013159","journal-title":"Clin Immunol"},{"key":"8625_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jdv.12311","volume":"28","author":"R Knobler","year":"2014","unstructured":"Knobler R, Berlin G, Calzavara-Pinton P et al (2014) Guidelines on the use of extracorporeal photopheresis. J Eur Acad Dermatol Venereol 28:1\u201337","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR83","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8","volume":"44","author":"AE Thompson","year":"2001","unstructured":"Thompson AE, Shea B, Welch V, Fenlon D, Pope JE (2001) Calcium-channel blockers for Raynaud\u2019s phenomenon in systemic sclerosis. Arthritis Rheum 44:1841\u20131847","journal-title":"Arthritis Rheum"},{"key":"8625_CR84","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1093\/rheumatology\/kev201","volume":"54","author":"M Hughes","year":"2015","unstructured":"Hughes M, Ong VH, Anderson ME et al (2015) Consensus best practice pathway of the UK scleroderma study group: digital vasculopathy in systemic sclerosis. Rheumatology 54:2015\u20132024","journal-title":"Rheumatology"},{"key":"8625_CR85","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1161\/CIRCULATIONAHA.104.523324","volume":"112","author":"R Fries","year":"2005","unstructured":"Fries R, Shariat K, von Wilmowsky H, Bohm M (2005) Sildenafil in the treatment of Raynaud\u2019s phenomenon resistant to vasodilatory therapy. Circulation 112:2980\u20132985","journal-title":"Circulation"},{"key":"8625_CR86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00296-016-3582-4","volume":"37","author":"R Foti","year":"2017","unstructured":"Foti R, Visalli E, Amato G et al (2017) Long-term clinical stabilization of scleroderma patients treated with a chronic and intensive IV iloprost regimen. Rheumatol Int 37:245\u2013249","journal-title":"Rheumatol Int"},{"key":"8625_CR87","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/acr.22018","volume":"65","author":"T Tingey","year":"2013","unstructured":"Tingey T, Shu J, Smuczek J et al (2013) Meta-analysis of healing and prevention of digital ulcers in systemic sclerosis. Arthritis Care Res (Hoboken) 65:1460\u20131471","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8625_CR88","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/0394632015606846","volume":"29","author":"A Cata De","year":"2016","unstructured":"De Cata A, Inglese M, Molinaro F et al (2016) Digital ulcers in scleroderma patients: a retrospective observational study. Int J Immunopathol Pharmacol 29:180\u2013187","journal-title":"Int J Immunopathol Pharmacol"},{"key":"8625_CR89","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/archdermatol.2011.2052","volume":"148","author":"SJ Balin","year":"2012","unstructured":"Balin SJ, Wetter DA, Andersen LK, Davis MD (2012) Calcinosis cutis occurring in association with autoimmune connective tissue disease: the Mayo Clinic experience with 78 patients, 1996\u20132009. Arch Dermatol 148:455\u2013462","journal-title":"Arch Dermatol"},{"key":"8625_CR90","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1529-8019.2012.01492.x","volume":"25","author":"A Gutierrez Jr","year":"2012","unstructured":"Gutierrez A Jr, Wetter DA (2012) Calcinosis cutis in autoimmune connective tissue diseases. Dermatol Ther 25:195\u2013206","journal-title":"Dermatol Ther"},{"key":"8625_CR91","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/keu006","volume":"53","author":"G Dinsdale","year":"2014","unstructured":"Dinsdale G, Murray A, Moore T et al (2014) A comparison of intense pulsed light and laser treatment of telangiectases in patients with systemic sclerosis: a within-subject randomized trial. Rheumatology 53:1422\u20131430","journal-title":"Rheumatology"},{"key":"8625_CR92","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","volume":"16","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D (2017) Systemic sclerosis. Autoimmun Rev 16:377\u2013384","journal-title":"Autoimmun Rev"},{"key":"8625_CR93","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","volume":"16","author":"S Sanges","year":"2017","unstructured":"Sanges S, Rivi\u00e8re S, Mekinian A et al (2017) Intravenous immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature. Autoimmun Rev 16:377\u2013384","journal-title":"Autoimmun Rev"},{"key":"8625_CR94","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/14728214.2016.1257607","volume":"21","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Pope JE (2016) Emerging drugs and therapeutics for systemic sclerosis. Expert Opin Emerg Drugs 21:421\u2013430","journal-title":"Expert Opin Emerg Drugs"},{"key":"8625_CR95","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M et al (2010) Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 69:1809","journal-title":"Ann Rheum Dis"},{"key":"8625_CR96","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semarthrit.2014.05.010","volume":"44","author":"M Rubio-Rivas","year":"2014","unstructured":"Rubio-Rivas M, Royo C, Sime\u00f3n CP, Corbella X, Fonollosa V (2014) Mortality and survival in systemic sclerosis: systematic review and meta-analysis. Semin Arthritis Rheum 44:208\u2013219","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR97","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1590\/abd1806-4841.20152890","volume":"90","author":"MF Careta","year":"2015","unstructured":"Careta MF, Romiti R (2015) Localized scleroderma: clinical spectrum and therapeutic update. An Bras Dermatol 90:62\u201373","journal-title":"An Bras Dermatol"},{"key":"8625_CR98","first-page":"73","volume":"24","author":"LS Peterson","year":"1997","unstructured":"Peterson LS, Nelson AM, Su WP, Mason T, O\u2019Fallon WM, Gabriel SE (1997) The epidemiology of morphea (localized scleroderma) in Olmsted County 1960\u20131993. J Rheumatol 24:73\u201380","journal-title":"J Rheumatol"},{"key":"8625_CR99","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","volume":"45","author":"F Zulian","year":"2006","unstructured":"Zulian F, Athreya BH, Laxer R, Nelson AM, Feitosa de Oliveira SK, Punaro MG et al (2006) Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) 45:614\u2013620","journal-title":"Rheumatology (Oxford)"},{"key":"8625_CR100","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","volume":"28","author":"KJ Murray","year":"2002","unstructured":"Murray KJ, Laxer RM (2002) Scleroderma in children and adolescents. Rheum Dis Clin N Am 28:603\u2013624","journal-title":"Rheum Dis Clin N Am"},{"key":"8625_CR101","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","volume":"59","author":"S Christen-Zaech","year":"2008","unstructured":"Christen-Zaech S, Hakim MD, Afsar FS, Paller AS (2008) Pediatric morphea (localized scleroderma): review of 136 patients. J Am Acad Dermatol 59:385\u2013396","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR102","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","volume":"145","author":"JJ Leitenberger","year":"2009","unstructured":"Leitenberger JJ, Cayce RL, Haley RW, Adams-Huet B, Bergstresser PR, Jacobe HT (2009) Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases. Arch Dermatol 145:545\u2013550","journal-title":"Arch Dermatol"},{"key":"8625_CR103","first-page":"171","volume":"13","author":"AV Marzano","year":"2003","unstructured":"Marzano AV, Menni S, Parodi A, Borghi A, Fuligni A, Fabbri P et al (2003) Localized scleroderma in adults and children. Clinical and laboratory investigations on 239 cases. Eur J Dermatol 13:171\u2013176","journal-title":"Eur J Dermatol"},{"key":"8625_CR104","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/BOR.0b013e3283641f61","volume":"25","author":"F Zulian","year":"2013","unstructured":"Zulian F, Cuffaro G, Sperotto F (2013) Scleroderma in children: an update. Curr Opin Rheumatol 25:643\u2013650","journal-title":"Curr Opin Rheumatol"},{"key":"8625_CR105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-016-8563-6","volume":"52","author":"G Slobodin","year":"2017","unstructured":"Slobodin G, Rimar D (2017) Regulatory T cells in systemic sclerosis: a comprehensive review. Clin Rev Allergy Immunol 52:194\u2013201","journal-title":"Clin Rev Allergy Immunol"},{"key":"8625_CR106","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","volume":"70","author":"LS Peterson","year":"1995","unstructured":"Peterson LS, Nelson AM, Su WP (1995) Classification of morphea (localized scleroderma). Mayo Clin Proc 70:1068\u20131076","journal-title":"Mayo Clin Proc"},{"key":"8625_CR107","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","volume":"52","author":"F Zulian","year":"2005","unstructured":"Zulian F, Vallongo C, Woo P, Russo R, Ruperto N, Harper J et al (2005) Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52:2873\u20132881","journal-title":"Arthritis Rheum"},{"key":"8625_CR108","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/abd1806-4841.20142977","volume":"89","author":"CM Batista","year":"2014","unstructured":"Batista CM, Lemos MO, Franceschi LE, Basilio CB, Reis CM (2014) Case for diagnosis. An Bras Dermatol 89:671\u2013673","journal-title":"An Bras Dermatol"},{"key":"8625_CR109","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/pde.12434","volume":"32","author":"J Avancini","year":"2015","unstructured":"Avancini J, Valente NY, Romiti R (2015) Generalized lenticular atrophoderma of Pasini and Pierini. Pediatr Dermatol 32:389\u2013391","journal-title":"Pediatr Dermatol"},{"key":"8625_CR110","first-page":"753","volume":"150","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Zhang R, Kang D, Zhu W (2015) Atrophoderma of Pasini and Pierini in zosteriform distribution. G Ital Dermatol Venereol 150:753\u2013755","journal-title":"G Ital Dermatol Venereol"},{"key":"8625_CR111","first-page":"636","volume":"150","author":"B Tas","year":"2015","unstructured":"Tas B, Sar M (2015) Linear atrophoderma of Moulin: a distinct entity or blaschko-linear variant of atrophoderma of Pasini and Pierini? G Ital Dermatol Venereol 150:636\u2013638","journal-title":"G Ital Dermatol Venereol"},{"key":"8625_CR112","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12969-015-0036-6","volume":"13","author":"O Zahedi Niaki","year":"2015","unstructured":"Zahedi Niaki O, Sissons W, Nguyen VH, Zargham R, Jafarian F (2015) Linear atrophoderma of Moulin: an underrecognized entity. Pediatr Rheumatol Online J 13:39","journal-title":"Pediatr Rheumatol Online J"},{"key":"8625_CR113","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.sder.2007.02.005","volume":"26","author":"I Bielsa","year":"2007","unstructured":"Bielsa I, Ariza A (2007) Deep morphea. Semin Cutan Med Surg 26:90\u201395","journal-title":"Semin Cutan Med Surg"},{"key":"8625_CR114","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.1525-1470.1991.tb00936.x","volume":"8","author":"KA Kobayashi","year":"1991","unstructured":"Kobayashi KA, Lui H, Prendiville JS (1991) Solitary morphea profunda in a 5-year-old girl: case report and review of the literature. Pediatr Dermatol 8:292\u2013295","journal-title":"Pediatr Dermatol"},{"key":"8625_CR115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2133.1993.tb00156.x","volume":"128","author":"RS Kirsner","year":"1993","unstructured":"Kirsner RS, Pardes JB, Falanga V (1993) Solitary fibrosing paraspinal plaque: solitary morphea profunda. Br J Dermatol 128:99\u2013101","journal-title":"Br J Dermatol"},{"key":"8625_CR116","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2230.2004.01422.x","volume":"29","author":"J Azad","year":"2004","unstructured":"Azad J, Dawn G, Shaffrali FC, Holmes SC, Barnetson RJ, Forsyth A (2004) Does solitary morphea profunda progress? Clin Exp Dermatol 29:25\u201327","journal-title":"Clin Exp Dermatol"},{"key":"8625_CR117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000018321","volume":"200","author":"M Blaszczyk","year":"2000","unstructured":"Blaszczyk M, Krysicka-Janiger K, Jab\u0142o\u0144ska S (2000) Primary atrophic profound linear scleroderma. Dermatology 200:63\u201366","journal-title":"Dermatology"},{"key":"8625_CR118","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/(SICI)1097-4598(199707)20:7<890::AID-MUS16>3.0.CO;2-W","volume":"20","author":"A Malandrini","year":"1997","unstructured":"Malandrini A, Dotti MT, Federico A (1997) Selective ipsilateral neuromuscular involvement in a case of facial and somatic hemiatrophy. Muscle Nerve 20:890\u2013892","journal-title":"Muscle Nerve"},{"key":"8625_CR119","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/acr.20070","volume":"62","author":"AL Herrick","year":"2010","unstructured":"Herrick AL, Ennis H, Bhushan M, Silman AJ, Baildam EM (2010) Incidence of childhood linear scleroderma and systemic sclerosis in the UK and Ireland. Arthritis Care Res (Hoboken) 62:213\u2013218","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8625_CR120","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1440-0960.1992.tb00107.x","volume":"33","author":"JA Hatzis","year":"1992","unstructured":"Hatzis JA, Stratigos AJ, Dimopoulos JC, Tzermias CK, Orfanidou A, Bassioukas KC (1992) Linear scleroderma with severe leg deformity. Australas J Dermatol 33:155\u2013157","journal-title":"Australas J Dermatol"},{"key":"8625_CR121","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1085-5629(98)80059-X","volume":"17","author":"DL Tuffanelli","year":"1998","unstructured":"Tuffanelli DL (1998) Localized scleroderma. Semin Cutan Med Surg 17:27\u201333","journal-title":"Semin Cutan Med Surg"},{"key":"8625_CR122","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1875-9572(09)60081-4","volume":"50","author":"KL Chiang","year":"2009","unstructured":"Chiang KL, Chang KP, Wong TT, Hsu TR (2009) Linear scleroderma \u201cen coup de sabre\u201d: initial presentation as intractable partial seizures in a child. Pediatr Neonatol 50:294\u2013298","journal-title":"Pediatr Neonatol"},{"key":"8625_CR123","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","volume":"56","author":"MM Tollefson","year":"2007","unstructured":"Tollefson MM, Witman PM (2007) En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients. J Am Acad Dermatol 56:257\u2013263","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR124","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.410370519","volume":"37","author":"MH Chung","year":"1995","unstructured":"Chung MH, Sum J, Morrell MJ, Horoupian DS (1995) Intracerebral involvement in scleroderma en coup de sabre: report of case with neuropathologic findings. Ann Neurol 37:679\u2013681","journal-title":"Ann Neurol"},{"key":"8625_CR125","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00315664","volume":"237","author":"W L\u00fcer","year":"1990","unstructured":"L\u00fcer W, J\u00f6ckel D, Henze T, Schipper HI (1990) Progressive inflammatory lesions of the brain parenchyma in localized scleroderma of the head. J Neurol 237:379\u2013381","journal-title":"J Neurol"},{"key":"8625_CR126","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s001050050475","volume":"47","author":"U Jappe","year":"1996","unstructured":"Jappe U, H\u00f6lzle E, Ring J (1996) Parry Romberg syndrome. Review and new observations based on a case with unusual features. Hautarzt 47:599\u2013603","journal-title":"Hautarzt"},{"key":"8625_CR127","first-page":"125","volume":"48","author":"S Jablonska","year":"1998","unstructured":"Jablonska S, Blaszczyk M, Rosinska D (1998) Progressive facial hemiatrophy and sclero- derma en coup de sabre: clinical presentation and course as related to the onset in early childhood and young adults. Arch Argent Dermatol 48:125\u2013128","journal-title":"Arch Argent Dermatol"},{"key":"8625_CR128","first-page":"844","volume":"19","author":"TJA Lehmann","year":"1992","unstructured":"Lehmann TJA (1992) The Parry-Romberg syndrome of progressive facial hemiatrophy and linear scleroderma en coup de sabre. Mistaken diagnosis or overlaping conditions? J Rheumatol 19:844\u2013845","journal-title":"J Rheumatol"},{"key":"8625_CR129","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1046\/j.1528-1157.2001.45800.x","volume":"42","author":"J DeFelipe","year":"2001","unstructured":"DeFelipe J, Segura T, Arellano JI, Merch\u00e1n A, DeFelipe-Oroquieta J, Mart\u00edn P et al (2001) Neuropathological findings in a patient with epilepsy and the Parry-Romberg syndrome. Epilepsia 42:1198\u20131203","journal-title":"Epilepsia"},{"key":"8625_CR130","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1212\/WNL.50.6.1915","volume":"50","author":"AR Woolfenden","year":"1998","unstructured":"Woolfenden AR, Tong DC, Norbash AM, Albers GW (1998) Progressive facial hemiatrophy: abnormality of intracranial vasculature. Neurology 50:1915\u20131917","journal-title":"Neurology"},{"key":"8625_CR131","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-5945-1-9","volume":"1","author":"T Gambichler","year":"2001","unstructured":"Gambichler T, Kreuter A, Hoffmann K, Bechara FG, Altmeyer P, Jansen T (2001) Billateral linear scleroderma \u201cen coup de sabre\u201d associated with facial atrophy and neurological complications. BMC Dermatol 1:9","journal-title":"BMC Dermatol"},{"key":"8625_CR132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1001\/archneurpsyc.1945.02300080003001","volume":"54","author":"R Wartenberg","year":"1945","unstructured":"Wartenberg R (1945) Progressive facial hemiatrophy. Arch Neurol Psychiatr 54:75\u201396","journal-title":"Arch Neurol Psychiatr"},{"key":"8625_CR133","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jama.1927.02680390019007","volume":"88","author":"HG Wolf","year":"1927","unstructured":"Wolf HG, Ehrenclou AH (1927) Trophic disorders of central origin: report of a case of progressive facial hemiatrophy associated with a lipodistrophy and other metabolic derangements. JAMA 88:991\u2013994","journal-title":"JAMA"},{"key":"8625_CR134","first-page":"47","volume-title":"Collections from unpublished papers","author":"CH Parry","year":"1825","unstructured":"Parry CH (1825) Collections from unpublished papers, vol 178. Underwood, London, p 47"},{"key":"8625_CR135","first-page":"1997","volume":"30","author":"M Blaszczyk","year":"2003","unstructured":"Blaszczyk M, Kr\u00f3licki L, Krasu M, Glinska O, Jablonska S (2003) Progressive facial hemi- atrophy: central nervous system involvement and relationship with scleroderma en coup de sabre. J Rheumatol 30:1997\u20132004","journal-title":"J Rheumatol"},{"key":"8625_CR136","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-1-4615-4857-7_14","volume":"455","author":"M Blaszczyk","year":"1999","unstructured":"Blaszczyk M, Jablonska S (1999) Linear scleroderma en coup de sabre. Relationship with progressive facial hemiatrophy (PFH). Adv Exp Med Biol 455:101\u2013104","journal-title":"Adv Exp Med Biol"},{"key":"8625_CR137","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ad.2016.07.010","volume":"108","author":"S S\u00e1nchez-P\u00e9rez","year":"2017","unstructured":"S\u00e1nchez-P\u00e9rez S, Escandell-Gonz\u00e1lez I, Pinazo-Canales MI, Jord\u00e1-Cuevas E (2017) Bullous morphea: description of a new case and discussion of etiologic and pathogenic factors in bulla formation. Actas Dermosifiliogr 108:75\u201376","journal-title":"Actas Dermosifiliogr"},{"key":"8625_CR138","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/cup.12418","volume":"42","author":"A Fern\u00e1ndez Flores","year":"2015","unstructured":"Fern\u00e1ndez Flores A, Gatica Torres M, Tinoco Fragoso F, Garc\u00eda Hidalgo F, Garc\u00eda Hidalgo L, Monroy E et al (2015) Three cases of bullous morphea: histopathologic findings with implications regarding pathogenesis. J Cutan Pathol 42:144\u2013149","journal-title":"J Cutan Pathol"},{"key":"8625_CR139","first-page":"827","volume":"14","author":"SB Martinez","year":"2016","unstructured":"Martinez SB, Gargallo V, Romero FT, Martinez LA, Peralto JL, Mart\u00edn RL (2016) Generalized morphea with development of bullous lesions at the site of surgical scars. J Dtsch Dermatol Ges 14:827\u2013829","journal-title":"J Dtsch Dermatol Ges"},{"key":"8625_CR140","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/1346-8138.12427","volume":"41","author":"T Qu","year":"2014","unstructured":"Qu T, Fang K (2014) Bullous morphea arising at the site of a healed herpes zoster. J Dermatol 41:553\u2013554","journal-title":"J Dermatol"},{"key":"8625_CR141","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/archderm.1987.01660270088021","volume":"123","author":"V Falanga","year":"1987","unstructured":"Falanga V, Medsger TA Jr, Reichlin M (1987) Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea. Arch Dermatol 123:350\u2013353","journal-title":"Arch Dermatol"},{"key":"8625_CR142","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3899\/jrheum.080098","volume":"35","author":"T Arkachaisri","year":"2008","unstructured":"Arkachaisri T, Pino S (2008) Localized scleroderma severity index and global assessments: a pilot study of outcome instruments. J Rheumatol 35:650\u2013657","journal-title":"J Rheumatol"},{"key":"8625_CR143","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/ddg.12724","volume":"14","author":"A Kreuter","year":"2016","unstructured":"Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, Aberer E, Scharffetter-Kochanek K, Horneff G, Reil E, Weberschock T, Hunzelmann N (2016) German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges 14:199\u2013216","journal-title":"J Dtsch Dermatol Ges"},{"key":"8625_CR144","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","volume":"39","author":"BB Cunningham","year":"1998","unstructured":"Cunningham BB, Landells ID, Langman C et al (1998) Topical calcipotriolo for morphea\/linear scleroderma. J Am Acad Dermatol 39:211\u2013215","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR145","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","volume":"35","author":"C Stefanaki","year":"2008","unstructured":"Stefanaki C, Stefanaki K, Kontochristopoulos G et al (2008) Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study. J Dermatol 35:712\u2013718","journal-title":"J Dermatol"},{"key":"8625_CR146","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","volume":"10","author":"EB Kroft","year":"2009","unstructured":"Kroft EB, Groeneveld TJ, Seyger MM, de Jong EM (2009) Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study. Am J Clin Dermatol 10:181\u2013187","journal-title":"Am J Clin Dermatol"},{"key":"8625_CR147","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1365-2133.2008.09017.x","volume":"160","author":"EB Kroft","year":"2009","unstructured":"Kroft EB, Creemers MC, van den Hoogen FH, Boezeman JB, de Jong EM (2009) Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study. Br J Dermatol 160:1075\u20131082","journal-title":"Br J Dermatol"},{"key":"8625_CR148","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","volume":"64","author":"SC Li","year":"2012","unstructured":"Li SC, Torok KS, Pope E et al (2012) Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 64:1175\u20131185","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"8625_CR149","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2340\/00015555-2297","volume":"96","author":"JS Mertens","year":"2016","unstructured":"Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, de Jong EM, Seyger MM (2016) Use of mycophenolate Mofetil in patients with severe localized scleroderma resistant or intolerant to methotrexate. Acta Derm Venereol 96:510\u2013513","journal-title":"Acta Derm Venereol"},{"key":"8625_CR150","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","volume":"130","author":"P Joly","year":"1994","unstructured":"Joly P, Bamberger N, Crickx B, Belaich S (1994) Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients. Arch Dermatol 130:663\u2013664","journal-title":"Arch Dermatol"},{"key":"8625_CR151","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamadermatol.2015.3648","volume":"152","author":"NA Wright","year":"2016","unstructured":"Wright NA, Mazori DR, Patel M, Merola JF, Femia AN, Vleugels RA (2016) Epidemiology and treatment of eosinophilic fasciitis: an analysis of 63 patients from 3 tertiary care centers. JAMA Dermatol 152:97\u201399","journal-title":"JAMA Dermatol"},{"key":"8625_CR152","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.sder.2006.04.001","volume":"25","author":"F Rongioletti","year":"2006","unstructured":"Rongioletti F (2006) Lichen myxedematosus (papular mucinosis): new concepts and perspectives for an old disease. Semin Cutan Med Surg 25:100\u2013104","journal-title":"Semin Cutan Med Surg"},{"key":"8625_CR153","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaad.2013.01.007","volume":"69","author":"F Rongioletti","year":"2013","unstructured":"Rongioletti F, Merlo G, Cinotti E et al (2013) Scleromyxedema: a multicenter study of characteristics, comorbidities, course, and therapy in 30 patients. J Am Acad Dermatol 69:66","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR154","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1369\/0022155411411304","volume":"59","author":"JS Kim","year":"2011","unstructured":"Kim JS, Werth VP (2011) Identification of specific chondroitin sulfate species in cutaneous autoimmune disease. J Histochem Cytochem 59:780\u2013790","journal-title":"J Histochem Cytochem"},{"key":"8625_CR155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archderm.139.6.815","volume":"139","author":"F Rongioletti","year":"2003","unstructured":"Rongioletti F, Cattarini G, Sottofattori E, Rebora A (2003) Granulomatous reaction after intradermal injections of hyaluronic acid gel. Arch Dermatol 139:815\u2013816","journal-title":"Arch Dermatol"},{"key":"8625_CR156","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0190-9622(95)90007-1","volume":"33","author":"AM Dinneen","year":"1995","unstructured":"Dinneen AM, Dicken CH (1995) Scleromyxedema. J Am Acad Dermatol 33:37\u201343","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR157","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jaad.2015.12.021","volume":"74","author":"F Rongioletti","year":"2016","unstructured":"Rongioletti F, Merlo G, Carli C et al (2016) Histopathologic characteristics of scleromyxedema: a study of a series of 34 cases. J Am Acad Dermatol 74:1194\u20131200","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR158","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/j.1600-0560.2009.01386.x","volume":"37","author":"F Rongioletti","year":"2010","unstructured":"Rongioletti F, Cozzani E, Parodi A (2010) Scleromyxedema with an interstitial granulomatous-like pattern: a rare histologic variant mimicking granuloma annulare. J Cutan Pathol 37:1084\u20131087","journal-title":"J Cutan Pathol"},{"key":"8625_CR159","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2340\/00015555-1299","volume":"92","author":"M Bidier","year":"2012","unstructured":"Bidier M, Zschoche C, Gholam P et al (2012) Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Acta Derm Venereol 92:408","journal-title":"Acta Derm Venereol"},{"key":"8625_CR160","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11926-011-0220-8","volume":"14","author":"J Nashel","year":"2012","unstructured":"Nashel J, Steen V (2012) Scleroderma mimics. Curr Rheumatol Rep 14:39","journal-title":"Curr Rheumatol Rep"},{"key":"8625_CR161","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0b013e3181630835","volume":"87","author":"M Blum","year":"2008","unstructured":"Blum M, Wigley FM, Hummers LK (2008) Scleromyxedema: a case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG). Medicine (Baltimore) 87:10\u201320","journal-title":"Medicine (Baltimore)"},{"key":"8625_CR162","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jaad.2008.11.013","volume":"60","author":"JB Rey","year":"2009","unstructured":"Rey JB, Luria RB (2009) Treatment of scleromyxedema and dermatoneuro syndrome with intravenous immunoglobulin. J Am Acad Dermatol 60:1037\u20131041","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR163","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2340\/00015555-1299","volume":"92","author":"M Bidier","year":"2012","unstructured":"Bidier M, Zschoche C, Gholam P et al (2012) Scleromyxoedema: clinical follow-up after successful treatment with high-dose immunoglobulins reveals different long-term outcomes. Acta Derm Venereol 92:408\u2013409","journal-title":"Acta Derm Venereol"},{"key":"8625_CR164","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaad.2004.01.058","volume":"51","author":"JC Sansbury","year":"2004","unstructured":"Sansbury JC, Cocuroccia B, Jorizzo JL et al (2004) Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 51:126\u2013131","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.semarthrit.2007.10.015","volume":"38","author":"P Efthimiou","year":"2008","unstructured":"Efthimiou P, Blanco M (2008) Intravenous gammaglobulin and thalidomide may be an effective therapeutic combination in refractory scleromyxedema: case report and discussion of the literature. Semin Arthritis Rheum 38:188\u2013194","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR166","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/rheumatology\/ker209","volume":"50","author":"R Bos","year":"2011","unstructured":"Bos R, de Waal EG, Kuiper H et al (2011) Thalidomide and dexamethasone followed by autologous stem cell transplantation for scleromyxoedema. Rheumatology (Oxford) 50:1925\u20131926","journal-title":"Rheumatology (Oxford)"},{"key":"8625_CR167","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-0609.2012.01772.x","volume":"88","author":"J Ca\u00f1ueto","year":"2012","unstructured":"Ca\u00f1ueto J, Labrador J, Rom\u00e1n C et al (2012) The combination of bortezomib and dexamethasone is an efficient therapy for relapsed\/refractory scleromyxedema: a rare disease with new clinical insights. Eur J Haematol 88:450","journal-title":"Eur J Haematol"},{"key":"8625_CR168","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1016\/j.jaad.2004.03.023","volume":"51","author":"KB Horn","year":"2004","unstructured":"Horn KB, Horn MA, Swan J et al (2004) A complete and durable clinical response to high-dose dexamethasone in a patient with scleromyxedema. J Am Acad Dermatol 51:S120\u2013S123","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR169","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1111\/jdv.13272","volume":"29","author":"F Rongioletti","year":"2015","unstructured":"Rongioletti F, Kaiser F, Cinotti E et al (2015) Scleredema. A multicentre study of characteristics, comorbidities, course and therapy in 44 patients. J Eur Acad Dermatol Venereol 29:2399\u20132404","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.semarthrit.2006.01.004","volume":"35","author":"WH Beers","year":"2006","unstructured":"Beers WH, Ince A, Moore TL (2006) Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum 35:355\u2013359","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR171","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1468-3083.2006.01959.x","volume":"21","author":"V Lewerenz","year":"2007","unstructured":"Lewerenz V, Ruzicka T (2007) Scleredema adultorum associated with type 2 diabetes mellitus: a report of three cases. J Eur Acad Dermatol Venereol 21:560\u2013561","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR172","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-2133.1995.tb16962.x","volume":"132","author":"J Varga","year":"1995","unstructured":"Varga J, Gotta S, Li L, Sollberg S, Di Leonardo M (1995) Scleredema adultorum: case report and demonstration of abnormal expression of extracellular matrix genes in skin fibroblasts in vivo and in vitro. Br J Dermatol 132:992\u2013999","journal-title":"Br J Dermatol"},{"key":"8625_CR173","first-page":"41","volume":"65","author":"DI Ioannidou","year":"2001","unstructured":"Ioannidou DI, Krasagakis K, Stefanidou MP et al (2001) Scleredema adultorum of Buschke presenting as periorbital edema: a diagnostic challenge. J Am Acad Dermatol 65:41\u201344","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR174","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1365-4632.2010.04513.x","volume":"50","author":"P Morais","year":"2011","unstructured":"Morais P, Almeida M, Santos P, Azevedo F (2011) Scleredema of Buschke following mycoplasma pneumoniae respiratory infection. Int J Dermatol 50:454\u2013457","journal-title":"Int J Dermatol"},{"key":"8625_CR175","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00000372-200106000-00022","volume":"23","author":"F Rongioletti","year":"2001","unstructured":"Rongioletti F, Rebora A (2001) Cutaneous mucinoses: microscopic criteria for diagnosis. Am J Dermatopathol 23:257\u2013267","journal-title":"Am J Dermatopathol"},{"key":"8625_CR176","doi-asserted-by":"crossref","first-page":"217","DOI":"10.4103\/0019-5154.44798","volume":"53","author":"FJ Miyares","year":"2008","unstructured":"Miyares FJ, Kuriakose R, Deleu DT, El-Wahad NA, Al-Hail H (2008) Scleredema diabeticorum with unusual presentation and fatal outcome. Indian J Dermatol 53:217\u2013219","journal-title":"Indian J Dermatol"},{"key":"8625_CR177","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1346-8138.2007.00268.x","volume":"34","author":"T Xiao","year":"2007","unstructured":"Xiao T, Yang ZH, He CD, Chen HD (2007) Scleredema adultorum treated with narrow-band ultraviolet B phototherapy. J Dermatol 34:270\u2013272","journal-title":"J Dermatol"},{"key":"8625_CR178","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1600-0781.2010.00526.x","volume":"26","author":"J Y\u00fcksek","year":"2010","unstructured":"Y\u00fcksek J, Sezer E, K\u00f6seo\u011flu D, Marko\u00e7 F, Y\u0131ld\u0131z H (2010) Scleredema treated with broad-band ultraviolet a phototherapy plus colchicine. Photodermatol Photoimmunol Photomed 26:257\u2013260","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"8625_CR179","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.3109\/10428194.2012.738816","volume":"54","author":"P Szturz","year":"2013","unstructured":"Szturz P, Adam Z, Va\u0161k\u016f V, Feit J, Krej\u010d\u00ed M, Pour L, H\u00e1jek R, Mayer J (2013) Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment. Leuk Lymphoma 54:1324\u20131326","journal-title":"Leuk Lymphoma"},{"key":"8625_CR180","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1016\/j.jaad.2011.02.004","volume":"65","author":"FY Lee","year":"2011","unstructured":"Lee FY, Chiu HY, Chiu HC (2011) Treatment of acquired reactive perforating collagenosis with allopurinol incidentally improves scleredema diabeticorum. J Am Acad Dermatol 65:e115\u2013e117","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR181","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2133.2000.03426.x","volume":"142","author":"GI Stables","year":"2000","unstructured":"Stables GI, Taylor PC, Highet AS (2000) Scleredema associated with paraproteinaemia treated by extracorporeal photopheresis. Br J Dermatol 142:781\u2013783","journal-title":"Br J Dermatol"},{"key":"8625_CR182","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1001\/archderm.139.6.780","volume":"139","author":"AR Bowen","year":"2003","unstructured":"Bowen AR, Smith L, Zone JJ (2003) Scleredema adultorum of Buschke treated with radiation. Arch Dematol 139:780\u2013784","journal-title":"Arch Dematol"},{"key":"8625_CR183","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1001\/archdermatol.2012.1558","volume":"148","author":"MC Aichelburg","year":"2012","unstructured":"Aichelburg MC, Loewe R, Schicher N, Sator PG, Karlhofer FM, Stingl G, Jalili A (2012) Successful treatment of poststreptococcal scleredema adultorum Buschke with intravenous immunoglobulins. Arch Dermatol 148:1126\u20131128","journal-title":"Arch Dermatol"},{"key":"8625_CR184","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(00)02694-5","volume":"356","author":"SE Cowper","year":"2000","unstructured":"Cowper SE, Robin HS, Steinberg SM, Su LD, Gupta S, LeBoit PE (2000) Scleromyxoedema-like cutaneous diseases in renal-dialysis patients. Lancet 356:1000\u20131001","journal-title":"Lancet"},{"key":"8625_CR185","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jaad.2010.08.041","volume":"65","author":"M Girardi","year":"2011","unstructured":"Girardi M, Kay J, Elston DM, LeBoit PE, Abu-Alfa A, Cowper SE (2011) Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations. J Am Acad Dermatol 65:1095\u20131106.e7","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR186","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1525-139X.2007.00399.x","volume":"21","author":"EA Knopp","year":"2008","unstructured":"Knopp EA, Cowper SE (2008) Nephrogenic systemic fibrosis: early recognition and treatment. Semin Dial 21:123\u2013128","journal-title":"Semin Dial"},{"key":"8625_CR187","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ejrad.2008.01.024","volume":"66","author":"HS Thomsen","year":"2008","unstructured":"Thomsen HS, Marckmann P (2008) Extracellular Gd-CA: differences in prevalence of NSF. Eur J Radiol 66:180\u2013183","journal-title":"Eur J Radiol"},{"key":"8625_CR188","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00330-012-2597-9","volume":"23","author":"HS Thomsen","year":"2013","unstructured":"Thomsen HS, Morcos SK, Almen T et al (2013) Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR contrast medium safety committee guidelines. Eur Radiol 23:307\u2013318","journal-title":"Eur Radiol"},{"key":"8625_CR189","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1067\/S0022-3476(03)00538-9","volume":"143","author":"F Jan","year":"2003","unstructured":"Jan F, Segal JM, Dyer J, LeBoit P, Siegfried E, Frieden IJ (2003) Nephrogenic fibrosing dermopathy: two pediatric cases. J Pediatr 143:678\u2013681","journal-title":"J Pediatr"},{"key":"8625_CR190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1525-139X.2007.00269.x","volume":"20","author":"MA Perazella","year":"2007","unstructured":"Perazella MA, Rodby RA (2007) Gadolinium use in patients with kidney disease: a cause for concern. Semin Dial 20:179\u2013185","journal-title":"Semin Dial"},{"key":"8625_CR191","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1002\/jmri.21980","volume":"30","author":"BB Newton","year":"2009","unstructured":"Newton BB, Jimenez SA (2009) Mechanism of NSF: new evidence challenging the prevailing theory. J Magn Reson Imaging 30:1277\u20131283","journal-title":"J Magn Reson Imaging"},{"key":"8625_CR192","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","volume":"15","author":"SE Cowper","year":"2003","unstructured":"Cowper SE (2003) Nephrogenic fibrosing dermopathy: the first 6 years. Curr Opin Rheumatol 15:785\u2013790","journal-title":"Curr Opin Rheumatol"},{"key":"8625_CR193","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/jamadermatol.2015.0976","volume":"151","author":"KN Larson","year":"2015","unstructured":"Larson KN, Gagnon AL, Darling MD, Patterson JW, Cropley TG (2015) Nephrogenic systemic fibrosis manifesting a decade after exposure to gadolinium. JAMA Dermatol 151:1117\u20131120","journal-title":"JAMA Dermatol"},{"key":"8625_CR194","doi-asserted-by":"publisher","unstructured":"Chopra T, Kandukurti K, Shah S, Ahmed R, Panesar M (2012) Understanding nephrogenic systemic fibrosis. Int J Nephrol 912189. doi: 10.1155\/2012\/912189","DOI":"10.1155\/2012\/912189"},{"key":"8625_CR195","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ki.2008.76","volume":"73","author":"S Swaminathan","year":"2008","unstructured":"Swaminathan S, High WA, Ranville J, Horn TD, Hiatt K, Thomas M et al (2008) Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney Int 73:1413\u20131418","journal-title":"Kidney Int"},{"key":"8625_CR196","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaad.2006.10.047","volume":"56","author":"WA High","year":"2007","unstructured":"High WA, Ayers RA, Chandler J et al (2007) Gadolinium is detectable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:21","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR197","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/2229-5178.85990","volume":"2","author":"B Madke","year":"2011","unstructured":"Madke B, Khopkar U (2011) Nephrogenic systemic fibrosis. Indian Dermatol Online J 2:51\u201356","journal-title":"Indian Dermatol Online J"},{"key":"8625_CR198","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/cup.12187","volume":"40","author":"J Bhawan","year":"2013","unstructured":"Bhawan J, Perez-Chua TA, Goldberg L (2013) Sclerotic bodies beyond nephrogenic systemic fibrosis. J Cutan Pathol 40:812\u2013817","journal-title":"J Cutan Pathol"},{"key":"8625_CR199","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jaad.2006.10.048","volume":"56","author":"AS Boyd","year":"2007","unstructured":"Boyd AS, Zic JA, Abraham JL (2007) Gadolinium deposition in nephrogenic fibrosing dermopathy. J Am Acad Dermatol 56:27","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.jaad.2007.01.022","volume":"56","author":"WA High","year":"2007","unstructured":"High WA, Ayers RA, Cowper SE (2007) Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis. J Am Acad Dermatol 56:710","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR201","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1590\/S0365-05962012000400013","volume":"87","author":"AC Igreja","year":"2012","unstructured":"Igreja AC, Mesquita Kde C, Cowper SE, Costa IM (2012) Nephrogenic systemic fibrosis: concepts and perspective. An Bras Dermatol 87:597\u2013607","journal-title":"An Bras Dermatol"},{"key":"8625_CR202","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1468-3083.2011.04398.x","volume":"27","author":"TR Elmholdt","year":"2013","unstructured":"Elmholdt TR, Buus NH, Ramsing M, Olesen AB (2013) Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial. J Eur Acad Dermatol Venereol 27:779\u2013784","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR203","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.semarthrit.2005.08.002","volume":"35","author":"FA Mendoza","year":"2006","unstructured":"Mendoza FA, Artlett CM, Sandorfi N et al (2006) Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature. Semin Arthritis Rheum 35:238","journal-title":"Semin Arthritis Rheum"},{"key":"8625_CR204","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/ndt\/gfq693","volume":"26","author":"MC Cuffy","year":"2011","unstructured":"Cuffy MC, Singh M, Formica R et al (2011) Renal transplantation for nephrogenic systemic fibrosis: a case report and review of the literature. Nephrol Dial Transplant 26:1099\u20131101","journal-title":"Nephrol Dial Transplant"},{"key":"8625_CR205","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0019-5154.77554","volume":"56","author":"R Waikhom","year":"2011","unstructured":"Waikhom R, Taraphder A (2011) Nephrogenic systemic fibrosis: a brief review. Indian J Dermatol 56:54\u201358","journal-title":"Indian J Dermatol"},{"key":"8625_CR206","first-page":"46","volume":"1","author":"LE Shulman","year":"1974","unstructured":"Shulman LE (1974) Diffuse fasciite with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol 1:46\u201349","journal-title":"J Rheumatol"},{"key":"8625_CR207","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.berh.2012.08.001","volume":"26","author":"D Lebeaux","year":"2012","unstructured":"Lebeaux D, S\u00e8ne D (2012) Eosinophilic fasciitis (Shulman disease). Best Pract Res Clin Rheumatol 26:449\u2013458","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"8625_CR208","doi-asserted-by":"publisher","unstructured":"Mertens JS, Seyger MM, Thurlings RM, Radstake TR, de Jong EM (2017) Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol. doi: 10.1007\/s40257-017-0269-x","DOI":"10.1007\/s40257-017-0269-x"},{"key":"8625_CR209","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.revmed.2015.08.002","volume":"36","author":"D S\u00e8ne","year":"2015","unstructured":"S\u00e8ne D (2015) Eosinophilic fasciitis (Shulman\u2019s disease): diagnostic and therapeutic review. Rev Med Interne 36:738\u2013745","journal-title":"Rev Med Interne"},{"key":"8625_CR210","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2014.01.019","volume":"13","author":"I Pinal-Fernandez","year":"2014","unstructured":"Pinal-Fernandez I, Selva-O\u2019 Callaghan A, Grau JM (2014) Diagnosis and classification of eosinophilic fasciitis. Autoimmun Rev 13:379\u20133824","journal-title":"Autoimmun Rev"},{"key":"8625_CR211","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s10067-006-0525-6","volume":"26","author":"Y Endo","year":"2007","unstructured":"Endo Y, Tamura A, Matsushima Y, Iwasaki T, Hasegawa M, Nagai Y, Ishikawa O (2007) Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome. Clin Rheumatol 26:1445\u20131451","journal-title":"Clin Rheumatol"},{"key":"8625_CR212","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-4632.2007.03544.x","volume":"47","author":"L Bischoff","year":"2008","unstructured":"Bischoff L, Derk CT (2008) Eosinophilic fasciitis: demographics, disease pattern and response to treatment: report of 12 cases and review of the literature. Int J Dermatol 47:29\u201335","journal-title":"Int J Dermatol"},{"key":"8625_CR213","first-page":"1811","volume":"30","author":"C Toquet","year":"2003","unstructured":"Toquet C, Hamidou MA, Renaudin K, Jarry A, Foulc P, Barbarot S, Laboisse C, Mussini JM (2003) In situ immunophenotype of the inflammatory infiltrate in eosinophilic fasciitis. J Rheumatol 30:1811\u20131815","journal-title":"J Rheumatol"},{"key":"8625_CR214","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/1346-8138.12563","volume":"41","author":"Y Asano","year":"2014","unstructured":"Asano Y, Ihn H, Jinnin M, Tamaki Z, Tamaki K, Sato S (2014) Serum levels of matrix metalloproteinase-13 in patients with eosinophilic fasciitis. J Dermatol 41:746\u2013748","journal-title":"J Dermatol"},{"key":"8625_CR215","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/RHU.0b013e3181b0fca6","volume":"15","author":"RS Daniel","year":"2009","unstructured":"Daniel RS, Lavery S, Maize JC Jr, Brown AN, Bolster MB (2009) Unilateral eosinophilic fasciitis: an under-recognized subtype? J Clin Rheumatol 15:247\u2013249","journal-title":"J Clin Rheumatol"},{"key":"8625_CR216","unstructured":"Patterson J (2016) Disorders of collagen. In: Weedon\u2019s skin pathology, 4th edn. Elsevier, pp 348\u2013379"},{"key":"8625_CR217","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s10067-014-2777-x","volume":"34","author":"J Nashel","year":"2015","unstructured":"Nashel J, Steen V (2015) The use of an elevated aldolase in diagnosing and managing eosinophilic fasciitis. Clin Rheumatol 34:1481\u20131484","journal-title":"Clin Rheumatol"},{"key":"8625_CR218","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1365-2133.2004.06062.x","volume":"151","author":"M Jinnin","year":"2004","unstructured":"Jinnin M, Ihn H, Yamane K, Asano Y, Yazawa N, Tamaki K (2004) Serum levels of tissue inhibitor of metalloproteinase-1 and 2 in patients with eosinophilic fasciitis. Br J Dermatol 151:407\u2013412","journal-title":"Br J Dermatol"},{"key":"8625_CR219","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/ard.2007.076844","volume":"67","author":"F Dybowski","year":"2008","unstructured":"Dybowski F, Neuen-Jacob E, Braun J (2008) Eosinophilic fasciitis and myositis: use of imaging modalities for diagnosis and monitoring. Ann Rheum Dis 67:572\u2013574","journal-title":"Ann Rheum Dis"},{"key":"8625_CR220","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2169\/internalmedicine.55.6937","volume":"55","author":"R Kurimoto","year":"2016","unstructured":"Kurimoto R, Ikeda K, Nakagomi D, Nakajima H (2016) Eosinophilic fasciitis illustrated by [(18)F] FDG-PET\/CT. Intern Med 55:2321\u20132322","journal-title":"Intern Med"},{"key":"8625_CR221","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/rheumatology\/kev290","volume":"54","author":"S Mondal","year":"2015","unstructured":"Mondal S, Goswami RP, Sinha D, Ghosh A (2015) Ultrasound is a useful adjunct in diagnosis of eosinophilic fasciitis. Rheumatology 54:2041","journal-title":"Rheumatology"},{"key":"8625_CR222","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jamadermatol.2016.0048","volume":"152","author":"VS Oza","year":"2016","unstructured":"Oza VS, Walsh R, North J, Berger TG, Murase JE (2016) Treatment of eosinophilic fasciitis with Sirolimus. JAMA Dermatol 152:488\u2013490","journal-title":"JAMA Dermatol"},{"key":"8625_CR223","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jamadermatol.2016.2873","volume":"152","author":"JS Mertens","year":"2016","unstructured":"Mertens JS, Zweers MC, Kievit W, Knaapen HK, Gerritsen M, Radstake TR, van den Hoogen FH, Creemers MC, de Jong EM (2016) High-dose intravenous pulse methotrexate in patients with eosinophilic fasciitis. JAMA Dermatol 152:1262\u20131265","journal-title":"JAMA Dermatol"},{"key":"8625_CR224","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jaad.2008.07.042","volume":"59","author":"EB Kroft","year":"2008","unstructured":"Kroft EB, Berkhof NJ, van de Kerkhof PC, Gerritsen RM, de Jong EM (2008) Ultraviolet a phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 59:1017\u20131030","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR225","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1468-3083.2003.00587.x","volume":"17","author":"C Romano","year":"2003","unstructured":"Romano C, Rubegni P, De Aloe G, Stanghellini E, D\u2019Ascenzo G, Andreassi L, Fimiani M (2003) Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. J Eur Acad Dermatol Venereol 17:10\u201313","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"8625_CR226","doi-asserted-by":"crossref","first-page":"515.e1","DOI":"10.1016\/j.jaad.2011.11.961","volume":"66","author":"SR Hymes","year":"2012","unstructured":"Hymes SR, Alousi AM, Cowen EW (2012) Graft-versus-host disease: part I. Pathogenesis and clinical manifestations of graft-versus-host disease. J Am Acad Dermatol 66:515.e1\u2013515.18","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR227","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0190-9622(92)70005-Z","volume":"26","author":"O Chosidow","year":"1992","unstructured":"Chosidow O, Bagot M, Vernant JP, Roujeau JC, Cordonnier C, Kuentz M, Wechsler J, Andr\u00e9 C, Touraine R, Revuz J (1992) Sclerodermatous chronic graft-versus-host disease. Analysis of seven cases. J Am Acad Dermatol 26:49\u201355","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR228","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/icvts\/ivv122","volume":"21","author":"J Zhang","year":"2015","unstructured":"Zhang J, Chen F, Ueki T, Date H (2015) Imatinib for sclerodermatous graft-versus-host disease in lung transplantation. Interact Cardiovasc Thorac Surg 21:260\u2013262","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"8625_CR229","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1111\/pde.12794","volume":"33","author":"L Lazzeri","year":"2016","unstructured":"Lazzeri L, Tripo L, Pescitelli L, Ricceri F, Prignano F (2016) A pediatric case of Sclerodermatous graft-versus-host disease responsive to ultraviolet A1 phototherapy. Pediatr Dermatol 33:e99\u2013102","journal-title":"Pediatr Dermatol"},{"key":"8625_CR230","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.transci.2011.07.005","volume":"45","author":"E Bisaccia","year":"2011","unstructured":"Bisaccia E, Palangio M, Gonzalez J (2011) Long-term extracorporeal photochemotherapy in a pediatric patient with refractory sclerodermatous chronic graft-versus-host disease. Transfus Apher Sci 45:187\u2013190","journal-title":"Transfus Apher Sci"},{"key":"8625_CR231","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1046\/j.1365-2133.1996.116851.x","volume":"134","author":"SA Bell","year":"1996","unstructured":"Bell SA, Faust H, Mitterm\u00fcller J, Kolb HJ, Meurer M (1996) Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 134:848\u2013854","journal-title":"Br J Dermatol"},{"key":"8625_CR232","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2141.2004.04945.x","volume":"125","author":"MA Higman","year":"2004","unstructured":"Higman MA, Vogelsang GB (2004) Chronic graft versus host disease. Br J Haematol 125:435\u2013454","journal-title":"Br J Haematol"},{"key":"8625_CR233","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1365-2133.2006.07404.x","volume":"155","author":"JM White","year":"2006","unstructured":"White JM, Devereux S, Pagliuca A, Salisbury JR, du Vivier AW, Creamer D (2006) Koebnerizing sclerodermatous graft-versus-host disease caused by donor lymphocyte infusion and interferon-alpha. Br J Dermatol 155:621\u2013623","journal-title":"Br J Dermatol"},{"key":"8625_CR234","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4049\/jimmunol.1502190","volume":"197","author":"TA Delaney","year":"2016","unstructured":"Delaney TA, Morehouse C, Brohawn PZ, Groves C, Colonna M, Yao Y, Sanjuan M, Coyle AJ (2016) Type I IFNs regulate inflammation, vasculopathy, and fibrosis in chronic cutaneous graft-versus-host disease. J Immunol 197:42\u201350","journal-title":"J Immunol"},{"key":"8625_CR235","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2014-12-567834","volume":"125","author":"S Sarantopoulos","year":"2015","unstructured":"Sarantopoulos S, Ritz J (2015) Aberrant B-cell homeostasis in chronic GVHD. Blood 125:1703\u20131707","journal-title":"Blood"},{"key":"8625_CR236","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2009.04.003","volume":"15","author":"MA Kharfan-Dabaja","year":"2009","unstructured":"Kharfan-Dabaja MA, Mhaskar AR, Djulbegovic B, Cutler C, Mohty M, Kumar A (2009) Efficacy of rituximab in the setting of steroid-refractory chronic graft-versus-host disease: a systematic review and meta-analysis. Biol Blood Marrow Transplant 15:1005\u20131013","journal-title":"Biol Blood Marrow Transplant"},{"key":"8625_CR237","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/j.1365-2133.2007.07827.x","volume":"156","author":"JM White","year":"2007","unstructured":"White JM, Creamer D, du Vivier AW, Pagliuca A, Ho AY, Devereux S, Salisbury JR, Mufti GJ (2007) Sclerodermatous graft-versus-host disease: clinical spectrum and therapeutic challenges. Br J Dermatol 156:1032\u20131038","journal-title":"Br J Dermatol"},{"key":"8625_CR238","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/archderm.138.7.924","volume":"138","author":"PF Pe\u00f1as","year":"2002","unstructured":"Pe\u00f1as PF, Jones-Caballero M, Aragu\u00e9s M, Fern\u00e1ndez-Herrera J, Fraga J, Garcia-Diez A (2002) Sclerodermatous graft-vs-host disease. Clinical and pathological study of 17 patients. Arch Dermatol 138:924\u2013934","journal-title":"Arch Dermatol"},{"key":"8625_CR239","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jaad.2005.06.015","volume":"53","author":"JV Schaffer","year":"2005","unstructured":"Schaffer JV, McNiff JM, Seropian S, Cooper DL, Bolognia JL (2005) Lichen sclerosus and eosinophilic fasciitis as manifestations of chronic graft-versus-host disease: expanding the sclerodermoid spectrum. J Am Acad Dermatol 53:591\u2013601","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR240","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjd.12828","volume":"171","author":"M Jachiet","year":"2014","unstructured":"Jachiet M, de Masson A, Peffault de Latour R, Rybojad M, Robin M, Bourhis JH, Xhaard A, Dhedin N, Sicre de Fontbrune F, Suarez F, Barete S, Parquet N, Nguyen S, Ades L, Rubio MT, Wittnebel S, Bagot M, Soci\u00e9 G, Bouaziz JD (2014) Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity. Br J Dermatol 171:63\u201368","journal-title":"Br J Dermatol"},{"key":"8625_CR241","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1365-2133.2010.09667.x","volume":"162","author":"BN Akay","year":"2010","unstructured":"Akay BN, Sanli H, Topcuoglu P, Arat M, Akyol A (2010) Nailfold capillary abnormalities are prevalent in sclerodermoid graft-versus-host disease and readily detected with dermatoscopy. Br J Dermatol 162:1076\u20131082","journal-title":"Br J Dermatol"},{"key":"8625_CR242","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2310\/7750.2010.09034","volume":"14","author":"J Man","year":"2010","unstructured":"Man J, Man J, Kalisiak M, Birchall IW, Salopek TG (2010) Chronic cutaneous graft-versus-host disease manifesting as calcinosis cutis universalis on a background of widespread sclerodermatoid changes. J Cutan Med Surg 14:249\u2013253","journal-title":"J Cutan Med Surg"},{"key":"8625_CR243","doi-asserted-by":"crossref","first-page":"e417","DOI":"10.1111\/j.1600-0846.2012.00659.x","volume":"19","author":"A Osmola-Ma\u0144kowska","year":"2013","unstructured":"Osmola-Ma\u0144kowska A, Silny W, Da\u0144czak-Pazdrowska A, Pola\u0144ska A, Olek-Hrab K, Sadowska-Przytocka A, \u017baba R, Jenerowicz D (2013) Assessment of chronic sclerodermoid graft-versus-host disease patients, using 20 MHz high-frequency ultrasonography and cutometer methods. Skin Res Technol 19:e417\u2013e422","journal-title":"Skin Res Technol"},{"key":"8625_CR244","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1610-0387.2007.06591.x","volume":"6","author":"MR Carcagn\u00ec","year":"2008","unstructured":"Carcagn\u00ec MR, De Aloe G, D\u2019Ascenzo G, Rubegni P, Fimiani M (2008) Extracorporeal photopheresis in graft-versus-host disease. J Dtsch Dermatol Ges 6:451\u2013457","journal-title":"J Dtsch Dermatol Ges"},{"key":"8625_CR245","first-page":"1169","volume":"88","author":"P Calzavara Pinton","year":"2003","unstructured":"Calzavara Pinton P, Porta F, Izzi T, Venturini M, Capezzera R, Zane C, Notarangelo LD (2003) Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica 88:1169\u20131175","journal-title":"Haematologica"},{"key":"8625_CR246","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1525-1470.2010.01301.x","volume":"28","author":"J Lazar","year":"2011","unstructured":"Lazar J, Poonawalla T, Teng JM (2011) A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy. Pediatr Dermatol 28:172\u2013175","journal-title":"Pediatr Dermatol"},{"key":"8625_CR247","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1083-8791(03)00151-4","volume":"9","author":"M Pines","year":"2003","unstructured":"Pines M, Snyder D, Yarkoni S, Nagler A (2003) Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. Biol Blood Marrow Transplant 9:417\u2013425","journal-title":"Biol Blood Marrow Transplant"},{"key":"8625_CR248","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(05)70154-9","volume":"365","author":"R Kauppinen","year":"2005","unstructured":"Kauppinen R (2005) Porphyrias. Lancet 365:241\u2013252","journal-title":"Lancet"},{"key":"8625_CR249","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2169\/internalmedicine.49.2888","volume":"49","author":"T Amezyane","year":"2010","unstructured":"Amezyane T, Abouzahir A, Fatihi J, Sekkach Y, Mahassin F, Sedrati O, Ghafir D, Ohayon V (2010) A sclerodermiform porphyria cutanea tarda. Intern Med 49:205\u2013206","journal-title":"Intern Med"},{"key":"8625_CR250","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1684\/ejd.2015.2556","volume":"25","author":"B Kranzelbinder","year":"2015","unstructured":"Kranzelbinder B, Wiednig M, El-Shabrawi-Caelen L, Aberer W, Aberer E (2015) Sclerodermiform porphyria cutanea tarda after torasemide. Eur J Dermatol 25:484\u2013485","journal-title":"Eur J Dermatol"},{"key":"8625_CR251","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00105-014-2783-6","volume":"65","author":"E Wallaeys","year":"2014","unstructured":"Wallaeys E, Thierling U, Lang E, Neumann NJ, Frank J (2014) Porphyria cutanea tarda with sclerodermatous changes and hemochromatosis. Hautarzt 65:272\u2013274","journal-title":"Hautarzt"},{"key":"8625_CR252","first-page":"671","volume":"46","author":"HW Lim","year":"1989","unstructured":"Lim HW (1989) Mechanisms of phototoxicity in porphyria cutanea tarda and erythropoietic protoporphyria. Immunol Ser 46:671\u2013685","journal-title":"Immunol Ser"},{"key":"8625_CR253","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000248396","volume":"178","author":"W Torinuki","year":"1989","unstructured":"Torinuki W, Kudoh K, Tagami H (1989) Increased mast cell numbers in the sclerotic skin of Porphyria Cutanea Tarda. Dermatologica 178:75\u201378","journal-title":"Dermatologica"},{"key":"8625_CR254","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2230.2007.02579.x","volume":"33","author":"CL Thomas","year":"2008","unstructured":"Thomas CL, Badminton MN, Rendall JR, Anstey AV (2008) Sclerodermatous changes of face, neck and scalp associated with familial porphyria cutanea tarda. Clin Exp Dermatol 33:422\u2013442","journal-title":"Clin Exp Dermatol"},{"key":"8625_CR255","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.annder.2013.04.092","volume":"140","author":"R Khayat","year":"2013","unstructured":"Khayat R, Dupuy A, Pans\u00e9 I, Bagot M, Cordoliani F (2013) Sclerodermatous changes in porphyria cutanea tarda: six cases. Ann Dermatol Venereol 140:589\u2013597","journal-title":"Ann Dermatol Venereol"},{"key":"8625_CR256","first-page":"203","volume":"85","author":"R Zemtsov","year":"2010","unstructured":"Zemtsov R, Zemtsov A (2010) Porphyria cutanea tarda presenting as scleroderma. Cutis 85:203\u2013205","journal-title":"Cutis"},{"key":"8625_CR257","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","volume":"95","author":"ZJ Bulaj","year":"2000","unstructured":"Bulaj ZJ, Phillips JD, Ajioka RS, Franklin MR, Griffen LM, Guinee DJ et al (2000) Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. Blood 95:1565\u20131571","journal-title":"Blood"},{"key":"8625_CR258","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1590\/S0365-05962010000600008","volume":"85","author":"FM Vieira","year":"2010","unstructured":"Vieira FM, Aoki V, Oliveira ZN, Martins JE (2010) Study of direct immunofluorescence, immunofluorescence mapping and light microscopy in porphyria cutanea tarda. An Bras Dermatol 85:827\u2013837","journal-title":"An Bras Dermatol"},{"key":"8625_CR259","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","volume":"10","author":"AK Singal","year":"2012","unstructured":"Singal AK, Kormos-Hallberg C, Lee C, Sadagoparamanujam VM, Grady JJ, Freeman DH Jr, Anderson KE (2012) Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol 10:1402\u20131409","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8625_CR260","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.cgh.2012.08.038","volume":"10","author":"AK Singal","year":"2012","unstructured":"Singal AK, Kormos-Hallberg C, Lee C et al (2012) Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol 10:1402","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8625_CR261","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000029891","volume":"12","author":"A Monastirli","year":"1999","unstructured":"Monastirli A, Georgiou S, Bolsen K et al (1999) Treatment of porphyria cutanea tarda with oral thalidomide. Skin Pharmacol Appl Ski Physiol 12:305","journal-title":"Skin Pharmacol Appl Ski Physiol"},{"key":"8625_CR262","first-page":"50","volume":"22","author":"S Ayres Jr","year":"1978","unstructured":"Ayres S Jr, Mihan R (1978) Porphyria cutanea tarda: response to vitamin E. A review and two case reports. Cutis 22:50","journal-title":"Cutis"},{"key":"8625_CR263","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cuor.2004.02.007","volume":"18","author":"JA Ballantyne","year":"2004","unstructured":"Ballantyne JA, Hooper G (2004) The hand and diabetes. Curr Orthop 18:118\u2013125","journal-title":"Curr Orthop"},{"key":"8625_CR264","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.diabet.2010.09.008","volume":"37","author":"S Ravindran Rajendran","year":"2011","unstructured":"Ravindran Rajendran S, Bhansali A, Walia R et al (2011) Prevalence and pattern of hand soft-tissue changes in type 2 diabetes mellitus. Diabetes Metab 37:312\u2013317","journal-title":"Diabetes Metab"},{"key":"8625_CR265","doi-asserted-by":"crossref","first-page":"e1575","DOI":"10.1097\/MD.0000000000001575","volume":"94","author":"LH Chen","year":"2015","unstructured":"Chen LH, Li C-Y, Kuo LC, Wang L-Y, Kuo KN, Jou IM, Hou W-H (2015) Risk of hand syndromes in patients with diabetes mellitus. A population-based cohort study in Taiwan. Medicine 94:e1575","journal-title":"Medicine"},{"key":"8625_CR266","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.diabres.2011.07.012","volume":"94","author":"HY Al-Matubsi","year":"2011","unstructured":"Al-Matubsi HY, Hamdan F, Alhanbali OA et al (2011) Diabetic hand syndromes as a clinical and diagnostic tool for diabetes mellitus patients. Diabetes Res Clin Pract 94:225\u2013229","journal-title":"Diabetes Res Clin Pract"},{"key":"8625_CR267","first-page":"118","volume":"28","author":"P Somai","year":"2011","unstructured":"Somai P (2011) Limited joint mobility in diabetes mellitus: the clinical implications. J Musculoskel Med 28:118\u2013124","journal-title":"J Musculoskel Med"},{"key":"8625_CR268","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1475-2840-12-125","volume":"12","author":"Y Ishibashi","year":"2013","unstructured":"Ishibashi Y, Matsui T, Maeda S, Higashimoto Y, Yamagishi S (2013) Advanced glycation end products evoke endothelial cell damage by stimulating soluble dipeptidyl peptidase-4 production and its interaction with mannose 6-phosphate\/insulin-like growth factor II receptor. Cardiovasc Diabetol 12:125","journal-title":"Cardiovasc Diabetol"},{"key":"8625_CR269","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/humu.23128","volume":"38","author":"K Yokote","year":"2017","unstructured":"Yokote K, Chanprasert S, Lee L, Eirich K, Takemoto M, Watanabe A et al (2017) WRN mutation update: mutation spectrum, patient registries, and translational prospects. Hum Mutat 38:7\u201315","journal-title":"Hum Mutat"},{"key":"8625_CR270","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/ph9020023","volume":"9","author":"T Davis","year":"2016","unstructured":"Davis T, Brook AJ, Rokicki MJ, Bagley MC, Kipling D (2016) Evaluating the role of p38 MAPK in the accelerated cell senescence of Werner syndrome fibroblasts. Pharmaceuticals 9:23","journal-title":"Pharmaceuticals"},{"key":"8625_CR271","first-page":"13","volume":"7","author":"M Goto","year":"2013","unstructured":"Goto M, Ishikawa Y, Sugimoto M, Furuichi Y (2013) Werner syndrome: a changing pattern of clinical manifestations in Japan (1917\u20132008). BioScience Trends 7:13\u201322","journal-title":"BioScience Trends"},{"key":"8625_CR272","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/jid.2015.88","volume":"135","author":"RJ Monnat Jr","year":"2015","unstructured":"Monnat RJ Jr (2015) \u201c...rewritten in the skin\u201d: clues to skin biology and aging from inherited disease. J Invest Dermatol 135:1484\u20131490","journal-title":"J Invest Dermatol"},{"key":"8625_CR273","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1086\/302718","volume":"66","author":"YA Lee","year":"2000","unstructured":"Lee YA, Stevens HP, Delaporte E, Wahn U, Reis A (2000) A gene for an autosomal dominant scleroatrophic syndrome predisposing to skin cancer (Huriez syndrome) maps to chromosome 4q23. Am J Hum Genet 66:326\u2013330","journal-title":"Am J Hum Genet"},{"key":"8625_CR274","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1096\/fj.09-137133","volume":"24","author":"L Massip","year":"2010","unstructured":"Massip L, Garand C, Paquet ER, Cogger VC, O\u2019Reilly JN, Tworek L, Hatherell A, Taylor CG, Thorin E, Zahradka P, Le Couteur DG, Lebel M (2010) Vitamin C restores healthy aging in a mouse model for Werner syndrome. FASEB J 24:158\u2013172","journal-title":"FASEB J"},{"key":"8625_CR275","doi-asserted-by":"crossref","first-page":"32038","DOI":"10.1038\/srep32038","volume":"6","author":"M Tokita","year":"2016","unstructured":"Tokita M, Kennedy SR, Risques RA, Chun SG, Pritchard C, Oshima J, Liu Y, Bryant-Greenwood PK, Welcsh P, Monnat RJ (2016) Werner syndrome through the lens of tissue and tumour genomics. Sci Rep 6:32038","journal-title":"Sci Rep"},{"key":"8625_CR276","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2230.2006.02092.x","volume":"31","author":"K Kikuchi","year":"2006","unstructured":"Kikuchi K, Hoashi T, Yazawa N, Tamaki K (2006) Pseudoscleroderma associated with cancer. Clin Exp Dermatol 31:381\u2013383","journal-title":"Clin Exp Dermatol"},{"key":"8625_CR277","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/rheumatology\/ken367","volume":"47","author":"M Juarez","year":"2008","unstructured":"Juarez M, Marshall R, Denton C, Evely R (2008) Paraneoplastic scleroderma secondary to hairy cell leukaemia successfully treated with cladribine. Rheumatology 47:1734\u20131735","journal-title":"Rheumatology"},{"key":"8625_CR278","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1365-2133.2000.03579.x","volume":"142","author":"C Querfeld","year":"2000","unstructured":"Querfeld C, Sollberg S, Huerkamp C, Eckes B, Krieg T (2000) Pseudoscleroderma associated with lung cancer: correlation of collagen typ 1 and connective tissue growth factor gene expression. Br J Dermatol 142:1228\u20131233","journal-title":"Br J Dermatol"},{"key":"8625_CR279","first-page":"78","volume":"24","author":"H Jedlickova","year":"2016","unstructured":"Jedlickova H, Dur\u010dansk\u00e1 V, Va\u0161k\u016f V (2016) Paraneoplastic scleroderma: are there any clues? Acta Dermatovenerol Croat 24:78\u201380","journal-title":"Acta Dermatovenerol Croat"},{"key":"8625_CR280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5114\/reum.2016.60220","volume":"54","author":"M Marek","year":"2016","unstructured":"Marek M, Rudny R (2016) Scleroderma of geriatric age and scleroderma-like paraneoplastic syndrome\u2014description of two cases. Reumatologia 54:91\u201394","journal-title":"Reumatologia"},{"key":"8625_CR281","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1002\/art.30514","volume":"63","author":"JA Allen","year":"2011","unstructured":"Allen JA, Peterson A, Sufit R et al (2011) Post-epidemic eosinophilia-myalgia syndrome associated with L-tryptophan. Arthritis Rheum 63:3633\u20133639","journal-title":"Arthritis Rheum"},{"key":"8625_CR282","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(08)80566-X","volume":"26","author":"F Rongioletti","year":"1992","unstructured":"Rongioletti F, Rebora A (1992) Cutaneous toxic mucinosis. J Am Acad Dermatol 26:788\u2013790","journal-title":"J Am Acad Dermatol"},{"key":"8625_CR283","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0378-4274(99)00220-9","volume":"112","author":"D D\u2019Cruz","year":"2000","unstructured":"D\u2019Cruz D (2000) Autoimmune diseases associated with drugs, chemicals and environmental factors. Toxicol Lett 112:421\u2013432","journal-title":"Toxicol Lett"},{"key":"8625_CR284","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.autrev.2007.12.004","volume":"7","author":"R Foti","year":"2008","unstructured":"Foti R, Leonardi R, Rondinone R et al (2008) Scleroderma-like disorders. Autoimmun Rev 7:331\u2013339","journal-title":"Autoimmun Rev"},{"key":"8625_CR285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archderm.1994.01690010045005","volume":"130","author":"LD Kaufman","year":"1994","unstructured":"Kaufman LD, Gruber BL, Gomez-Reino JJ et al (1994) Fibrogenic growth factors in the eosinophilia\u2013myalgia syndrome and the toxic oil syndrome. Arch Dermatol 130:41\u201347","journal-title":"Arch Dermatol"},{"key":"8625_CR286","first-page":"76","volume":"52","author":"SK Sharma","year":"2004","unstructured":"Sharma SK, Handa R, Sood R et al (2004) Bleomycin-induced scleroderma. J Assoc Physicians India 52:76\u201377","journal-title":"J Assoc Physicians India"},{"key":"8625_CR287","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5114\/reum.2016.61212","volume":"54","author":"K Niklas","year":"2016","unstructured":"Niklas K, Niklas AA, Majewski D, Puszczewicz M (2016) Rheumatic diseases induced by drugs and environmental factors: the state-of-the-art\u2014part one. Reumatologia 54:122\u2013127","journal-title":"Reumatologia"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-017-8625-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8625-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-017-8625-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T14:42:40Z","timestamp":1719326560000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-017-8625-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,16]]},"references-count":287,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["8625"],"URL":"https:\/\/doi.org\/10.1007\/s12016-017-8625-4","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,16]]}}}